A new vulnerability in targeting blood cancer

06:22 EDT 21 May 2018 | ecancermedicalscience

AML is not a single disease. It is a group of leukemias that develop in the bone marrow from progenitors of specialized blood cells, the so-called myeloid cells. Rapidly growing and dividing, these aberrant cells crowd the bone marrow and bloodstream,...

Original Article: A new vulnerability in targeting blood cancer

More From BioPortfolio on "A new vulnerability in targeting blood cancer"